المؤلفون: Kwon, Soonil, Lee, So-Ryoung, Choi, Eue-Keun, Lee, Kyung-Yeon, Choi, JungMin, Ahn, Hyo-Jeong, Oh, Seil, Lip, Gregory Yoke Hong

المصدر: Kwon , S , Lee , S-R , Choi , E-K , Lee , K-Y , Choi , J , Ahn , H-J , Oh , S & Lip , G Y H 2024 , ' Perioperative Management in Patients with Atrial Fibrillation Treated with Non-Vitamin K Antagonist Oral Anticoagulants Undergoing Minor Bleeding Risk Procedure: Rationale and Protocol for the PERIXa Study ' , Vascular Health and Risk Management , vol. 20 , pp. 231-244 . https://doi.org/10.2147/VHRM.S455530Test

مصطلحات موضوعية: Administration, Oral, Atrial Fibrillation/diagnosis, Drug Administration Schedule, Factor Xa Inhibitors/adverse effects, Hemorrhage/chemically induced, Humans, Multicenter Studies as Topic, Perioperative Care/methods, Prospective Studies, Pyrazoles/adverse effects, Pyridines/adverse effects, Pyridones/adverse effects, Registries, Research Design, Risk Assessment, Risk Factors, Rivaroxaban/adverse effects, Thiazoles, Time Factors, Treatment Outcome, bleeding, oral anticoagulant, atrial fibrillation, perioperative care, direct factor Xa inhibitor

وصف الملف: application/pdf

العلاقة: https://vbn.aau.dk/da/publications/c745a5c9-6a22-436d-8bd0-4bf31d82a9d1Test

الإتاحة: https://doi.org/10.2147/VHRM.S455530Test
https://vbn.aau.dk/da/publications/c745a5c9-6a22-436d-8bd0-4bf31d82a9d1Test
https://vbn.aau.dk/ws/files/717193986/Kwon_et_al._2024_._Perioperative_Management_in_Patients_with_Atrial_Fibrillation_Treated_with_Non-Vitamin_K_Antagonist_Oral_Anticoagulants_Undergoing_Minor_Bleeding_Risk_Procedure_-_Rationale_and_Protocol_for_the_PERIXa_Study.pdfTest
http://www.scopus.com/inward/record.url?scp=85194026459&partnerID=8YFLogxKTest

المؤلفون: Romiti, Giulio Francesco, Proietti, Marco, Corica, Bernadette, Bonini, Niccolò, Boriani, Giuseppe, Huisman, Menno V., Lip, Gregory Y. H.

المصدر: Romiti , G F , Proietti , M , Corica , B , Bonini , N , Boriani , G , Huisman , M V , Lip , G Y H & GLORIA‐AF Investigators 2023 , ' Implications of Clinical Risk Phenotypes on the Management and Natural History of Atrial Fibrillation: A Report From the GLORIA-AF ' , Journal of the American Heart Association , vol. 12 , no. 20 , e030565 . https://doi.org/10.1161/JAHA.123.030565Test

مصطلحات موضوعية: Administration, Oral, Aged, 80 and over, Anticoagulants/adverse effects, Atrial Fibrillation/complications, Female, Hemorrhage/chemically induced, Humans, Male, Middle Aged, Registries, Risk Assessment, Risk Factors, Stroke/epidemiology, anticoagulation, atrial fibrillation, clinical complexity, outcomes, elderly individuals

وصف الملف: application/pdf

العلاقة: https://vbn.aau.dk/da/publications/50adeafe-59c7-47fa-ba13-80f77d20395fTest

الإتاحة: https://doi.org/10.1161/JAHA.123.030565Test
https://vbn.aau.dk/da/publications/50adeafe-59c7-47fa-ba13-80f77d20395fTest
https://vbn.aau.dk/ws/files/558119980/Romiti_et_al._2023_._Implications_of_Clinical_Risk_Phenotypes_on_the_Management_and_Natural_History_of_Atrial_Fibrillation_-_A_Report_From_the_GLORIA-AF.pdfTest
http://www.scopus.com/inward/record.url?scp=85175495000&partnerID=8YFLogxKTest

المساهمون: Daehoon Kim, Pil-Sung Yang, Jung-Hoon Sung, Eunsun Jang, Hee Tae Yu, Tae-Hoon Kim, Jae-Sun Uhm, Jong-Youn Kim, Hui-Nam Pak, Moon-Hyoung Lee, Gregory Y H Lip, Boyoung Joung, Kim, Dae Hoon

مصطلحات موضوعية: Administration, Oral, Aged, 80 and over, Anticoagulants / adverse effects, Atrial Fibrillation* / complications, Atrial Fibrillation* / drug therapy, Atrial Fibrillation* / epidemiology, Female, Frail Elderly, Frailty* / chemically induced, Frailty* / complications, Frailty* / drug therapy, Hemorrhage / chemically induced, Hemorrhage / complications, Hemorrhage / epidemiology, Humans, Ischemic Stroke, Male, Retrospective Studies, Risk Assessment, Risk Factors, Stroke* / drug therapy, Warfarin / adverse effects, Editorials, anticoagulant, atrial fibrillation, frailty, ischemic stroke, mortality

العلاقة: STROKE; J02690; OAK-2022-02907; https://ir.ymlib.yonsei.ac.kr/handle/22282913/189421Test; T202202430; STROKE, Vol.53(6) : 1873-1882, 2022-06

الإتاحة: https://doi.org/10.1161/STROKEAHA.121.036757Test
https://ir.ymlib.yonsei.ac.kr/handle/22282913/189421Test

المؤلفون: Binding, Casper, Blanche, Paul, Lip, Gregory Y. H., Kamper, Anne-Lise, Lee, Christina J. Y., Staerk, Laila, Gislason, Gunnar, Torp-Pedersen, Christian, Olesen, Jonas Bjerring, Bonde, Anders Nissen

المصدر: Binding , C , Blanche , P , Lip , G Y H , Kamper , A-L , Lee , C J Y , Staerk , L , Gislason , G , Torp-Pedersen , C , Olesen , J B & Bonde , A N 2024 , ' Efficacy and safety of oral anticoagulants according to kidney function among patients with atrial fibrillation ' , European Heart Journal - Cardiovascular Pharmacotherapy , vol. 10 , no. 3 , pvae016 , pp. 210-218 . https://doi.org/10.1093/ehjcvp/pvae016Test

مصطلحات موضوعية: Administration, Oral, Aged, 80 and over, Anticoagulants/adverse effects, Atrial Fibrillation/drug therapy, Denmark/epidemiology, Factor Xa Inhibitors/adverse effects, Female, Glomerular Filtration Rate/drug effects, Hemorrhage/chemically induced, Humans, Kidney/physiopathology, Male, Middle Aged, Pyrazoles/adverse effects, Pyridones/adverse effects, Registries, Risk Assessment, Risk Factors, Stroke/prevention & control, Thromboembolism/prevention & control, Time Factors, Treatment Outcome, Major bleeding, Direct oral anticoagulants, Stroke, Atrial fibrillation, Kidney function

العلاقة: https://vbn.aau.dk/da/publications/11c7eb9b-e927-4b12-99ff-a6b1d7cf36dcTest

الإتاحة: https://doi.org/10.1093/ehjcvp/pvae016Test
https://vbn.aau.dk/da/publications/11c7eb9b-e927-4b12-99ff-a6b1d7cf36dcTest
http://www.scopus.com/inward/record.url?scp=85194197727&partnerID=8YFLogxKTest

المؤلفون: McDermott, John Henry, Wolf, Joshua, Hoshitsuki, Keito, Huddart, Rachel, Caudle, Kelly E, Whirl-Carrillo, Michelle, Steyger, Peter S, Smith, Richard J H, Cody, Neal, Rodriguez-Antona, Cristina, Klein, Teri E, Newman, William G

المصدر: McDermott , J H , Wolf , J , Hoshitsuki , K , Huddart , R , Caudle , K E , Whirl-Carrillo , M , Steyger , P S , Smith , R J H , Cody , N , Rodriguez-Antona , C , Klein , T E & Newman , W G 2022 , ' Clinical Pharmacogenetics Implementation Consortium Guideline for the Use of Aminoglycosides Based on MT-RNR1 Genotype ' , Clinical Pharmacology and Therapeutics , vol. 111 , no. 2 , pp. 366-372 . https://doi.org/10.1002/cpt.2309Test

مصطلحات موضوعية: Aminoglycosides/adverse effects, Anti-Bacterial Agents/adverse effects, Clinical Decision-Making, Genotype, Hearing Loss, Sensorineural/chemically induced, Humans, Ototoxicity, Patient Safety, Pharmacogenetics, Pharmacogenomic Testing, Pharmacogenomic Variants, Predictive Value of Tests, RNA, Ribosomal/genetics, Risk Assessment, Risk Factors

الإتاحة: https://doi.org/10.1002/cpt.2309Test
https://research.manchester.ac.uk/en/publications/58236dd7-7fac-43e2-9135-55e90d643d39Test
https://www.mendeley.com/catalogue/43367b29-5561-3faa-895d-bb5f3df2fc98Test/

المؤلفون: Overvad, Thure Filskov, Ording, Anne Gulbech, Nielsen, Peter Brønnum, Skjøth, Flemming, Albertsen, Ida Ehlers, Noble, Simon, Vistisen, Anders Krog, Gade, Inger Lise, Severinsen, Marianne Tang, Piazza, Gregory, Larsen, Torben Bjerregaard

المصدر: Overvad , T F , Ording , A G , Nielsen , P B , Skjøth , F , Albertsen , I E , Noble , S , Vistisen , A K , Gade , I L , Severinsen , M T , Piazza , G & Larsen , T B 2022 , ' Validation of the Khorana score for predicting venous thromboembolism in 40 218 patients with cancer initiating chemotherapy ' , Blood Advances , vol. 6 , no. 10 , pp. 2967-2976 . https://doi.org/10.1182/bloodadvances.2021006484Test

مصطلحات موضوعية: Anticoagulants/therapeutic use, Female, Humans, Incidence, Pancreatic Neoplasms/chemically induced, Risk Assessment, Venous Thromboembolism/diagnosis

العلاقة: https://pure.au.dk/portal/da/publications/validation-of-the-khorana-score-for-predicting-venous-thromboembolism-in-40-218-patients-with-cancer-initiating-chemotherapyTest(299ac697-f43d-4031-adde-1ae9eada62b3).html

الإتاحة: https://doi.org/10.1182/bloodadvances.2021006484Test
https://pure.au.dk/portal/da/publications/validation-of-the-khorana-score-for-predicting-venous-thromboembolism-in-40-218-patients-with-cancer-initiating-chemotherapyTest(299ac697-f43d-4031-adde-1ae9eada62b3).html
http://www.scopus.com/inward/record.url?scp=85130598829&partnerID=8YFLogxKTest
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9131922/pdf/advancesADV2021006484.pdfTest

المؤلفون: Egeberg, Alexander, Schwarz, Peter, Harsløf, Torben, Andersen, Yuki M.F., Pottegård, Anton, Hallas, Jesper, Thyssen, Jacob P.

المصدر: Egeberg , A , Schwarz , P , Harsløf , T , Andersen , Y M F , Pottegård , A , Hallas , J & Thyssen , J P 2021 , ' Association of Potent and Very Potent Topical Corticosteroids and the Risk of Osteoporosis and Major Osteoporotic Fractures ' , JAMA Dermatology , vol. 157 , no. 3 , pp. 275-282 . https://doi.org/10.1001/jamadermatol.2020.4968Test

مصطلحات موضوعية: ADULT, ATOPIC-DERMATITIS, DIAGNOSIS, ECZEMA, GUIDELINES, MANAGEMENT, PATIENT, Risk Assessment, Humans, Middle Aged, Male, Mometasone Furoate/administration & dosage, Dose-Response Relationship, Drug, Osteoporosis/chemically induced, Denmark, Female, Registries, Aged, Retrospective Studies, Administration, Topical, Glucocorticoids/administration & dosage, Osteoporotic Fractures/chemically induced, Cohort Studies

الإتاحة: https://doi.org/10.1001/jamadermatol.2020.4968Test
https://pure.au.dk/portal/da/publications/association-of-potent-and-very-potent-topical-corticosteroids-and-the-risk-of-osteoporosis-and-major-osteoporotic-fracturesTest(1a012192-22e6-4142-b142-863cc3232769).html
http://www.scopus.com/inward/record.url?scp=85099823053&partnerID=8YFLogxKTest
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7970335/?report=printableTest

المؤلفون: Hershman, Dawn L, Unger, Joseph M, Crew, Katherine D, Minasian, Lori M, Awad, Danielle, Moinpour, Carol M, Hansen, Lisa, Lew, Danika L, Greenlee, Heather, Fehrenbacher, Louis, Wade, James L, 3rd, Wong, Siu-Fun, Hortobagyi, Gabriel N, Meyskens, Frank L, Albain, Kathy S

المصدر: Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 31(20)

مصطلحات موضوعية: Acetylcarnitine: administration & dosage, adverse effects, Adult, Aged, Breast Neoplasms: drug therapy, pathology, surgery, Chemotherapy, Adjuvant, Dietary Supplements, Dose-Response Relationship, Drug, Double-Blind Method, Drug Administration Schedule, Female, Follow-Up Studies, Humans, Linear Models, Mastectomy: methods, Middle Aged, Multivariate Analysis, Nerve Regeneration: drug effects, Peripheral Nervous System Diseases: chemically induced, prevention & control, Reference Values, Risk Assessment, Sensitivity and Specificity, Severity of Illness Index, Taxoids: adverse effects, therapeutic use, Treatment Outcome, acetylcarnitine, taxoid, adjuvant chemotherapy, adult, aged, article, breast tumor, chemically induced disorder, comparative study, controlled clinical trial, controlled study, diet supplementation, dose response, double blind procedure, drug administration, drug effect, female, follow up, human, mastectomy, methodology, middle aged, multivariate analysis, nerve regeneration, pathology, peripheral neuropathy, randomized controlled trial, reference value, risk assessment, sensitivity and specificity, severity of illness index, statistical model, treatment outcome, Acetylcarnitine, Adult, Aged, Breast Neoplasms, Chemotherapy, Adjuvant, Dietary Supplements, Dose-Response Relationship, Drug, Double-Blind Method, Drug Administration Schedule, Female, Follow-Up Studies, Humans, Linear Models, Mastectomy, Middle Aged, Multivariate Analysis, Nerve Regeneration, Peripheral Nervous System Diseases, Reference Values, Risk Assessment, Sensitivity and Specificity, Severity of Illness Index, Taxoids, Treatment Outcome

وصف الملف: application/pdf

الوصول الحر: https://escholarship.org/uc/item/4ph1164gTest

المساهمون: Francesco Costa, David van Klaveren, Antonio Colombo, Fausto Feres, Lorenz Räber, Thomas Pilgrim, Myeong-Ki Hong, Hyo-Soo Kim, Stephan Windecker, Ewout W Steyerberg, Marco Valgimigli, Hong, Myeong Ki

مصطلحات موضوعية: Age Factors, Clinical Decision-Making, Dual Anti-Platelet Therapy / standards, Duration of Therapy, Hemorrhage / chemically induced, Hemorrhage / epidemiology, Humans, Percutaneous Coronary Intervention, Platelet Aggregation Inhibitors / adverse effects, Platelet Aggregation Inhibitors / therapeutic use, Postoperative Complications / chemically induced, Postoperative Complications / epidemiology, Risk Assessment

العلاقة: AMERICAN HEART JOURNAL; J00069; OAK-2022-03744; https://ir.ymlib.yonsei.ac.kr/handle/22282913/190116Test; https://www.sciencedirect.com/science/article/pii/S0002870320300296Test; T9992020340; AMERICAN HEART JOURNAL, Vol.223 : 44-47, 2020-05

الإتاحة: https://doi.org/10.1016/j.ahj.2020.01.014Test
https://ir.ymlib.yonsei.ac.kr/handle/22282913/190116Test
https://www.sciencedirect.com/science/article/pii/S0002870320300296Test

المساهمون: Marco Valgimigli, Felice Gragnano, Mattia Branca, Anna Franzone, Usman Baber, Yangsoo Jang, Takeshi Kimura, Joo-Yong Hahn, Qiang Zhao, Stephan Windecker, Charles M Gibson, Byeong-Keuk Kim, Hirotoshi Watanabe, Young Bin Song, Yunpeng Zhu, Pascal Vranckx, Shamir Mehta, Sung-Jin Hong, Kenji Ando, Hyeon-Cheol Gwon, Patrick W Serruys, George D Dangas, Eùgene P McFadden, Dominick J Angiolillo, Dik Heg 5, Peter Jüni, Roxana Mehran, Kim, Byeong Keuk

مصطلحات موضوعية: Aged, Coronary Artery Disease / drug therapy, Coronary Artery Disease / surgery, Dual Anti-Platelet Therapy / adverse effects, Dual Anti-Platelet Therapy / methods, Female, Hemorrhage / chemically induced, Hemorrhage / epidemiology, Humans, Male, Middle Aged, Mortality / trends, Myocardial Infarction / epidemiology, Myocardial Infarction / prevention & control, Outcome Assessment, Health Care, Percutaneous Coronary Intervention / adverse effects, Percutaneous Coronary Intervention / mortality, Percutaneous Coronary Intervention / standards, Purinergic P2Y Receptor Antagonists / adverse effects, Purinergic P2Y Receptor Antagonists / therapeutic use, Randomized Controlled Trials as Topic, Risk Assessment, Stroke / epidemiology, Stroke / prevention & control, Thrombosis / drug therapy, Thrombosis / prevention & control

العلاقة: BMJ-BRITISH MEDICAL JOURNAL; J00419; OAK-2022-05024; OAK-2022-05025; OAK-2022-05026; https://ir.ymlib.yonsei.ac.kr/handle/22282913/190889Test; T9992022300; BMJ-BRITISH MEDICAL JOURNAL, Vol.373, 2021-06

الإتاحة: https://doi.org/10.1136/bmj.n1332Test
https://ir.ymlib.yonsei.ac.kr/handle/22282913/190889Test